Thu, March 3, 2022
Wed, March 2, 2022
Tue, March 1, 2022
Mon, February 28, 2022
Sun, February 27, 2022
Fri, February 25, 2022

Douglas Miehm Maintained (AUPH) at Buy with Decreased Target to $27 on, Mar 1st, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-27-on-mar-1st-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Douglas Miehm of RBC Capital, Maintained "Aurinia Pharmaceuticals Inc." (AUPH) at Buy with Decreased Target from $31 to $27 on, Mar 1st, 2022.

Douglas has made no other calls on AUPH in the last 4 months.



There are 3 other peers that have a rating on AUPH. Out of the 3 peers that are also analyzing AUPH, 0 agree with Douglas's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Douglas


  • Justin Kim of "Oppenheimer" Upgraded from Hold to Buy and Decreased Target to $31 on, Friday, December 10th, 2021
  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $40 on, Thursday, November 4th, 2021
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $35 on, Thursday, November 4th, 2021

Publication Contributing Sources